Shared genetic factors in migraine and depression
Evidence from a genetic isolate
Abstract
Objective: To investigate the co-occurrence of migraine and depression and assess whether shared genetic factors may underlie both diseases.
Methods: Subjects were 2,652 participants of the Erasmus Rucphen Family genetic isolate study. Migraine was diagnosed using a validated 3-stage screening method that included a telephone interview. Symptoms of depression were assessed using the Center for Epidemiologic Studies Depression scale and the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). The contribution of shared genetic factors in migraine and depression was investigated by comparing heritability estimates for migraine with and without adjustment for symptoms of depression, and by comparing the heritability scores of depression between migraineurs and controls.
Results: We identified 360 migraine cases: 209 had migraine without aura (MO) and 151 had migraine with aura (MA). Odds ratios for depression in patients with migraine were 1.29 (95% confidence interval [CI] 0.98–1.70) for MO and 1.70 (95% CI 1.28–2.24) for MA. Heritability estimates were significant for all migraine (0.56), MO (0.77), and MA (0.96), and decreased after adjustment for symptoms of depression or use of antidepressant medication, in particular for MA. Comparison of the heritability scores for depression between patients with migraine and controls showed a genetic correlation between HADS-D score and MA.
Conclusions: There is a bidirectional association between depression and migraine, in particular migraine with aura, which can be explained, at least partly, by shared genetic factors.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
REFERENCES
1.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004;24:1–160.
2.
Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003;60:1308–1312.
3.
Breslau N, Davis GC, Schultz LR, Peterson EL. Joint 1994 Wolff Award Presentation: Migraine and major depression: a longitudinal study. Headache 1994;34:387–393.
4.
Breslau N, Schultz LR, Stewart WF, et al. Headache and major depression: is the association specific to migraine? Neurology 2000;54:308–313.
5.
Kecceci H, Dener S, Analan E. Co-morbidity of migraine and major depression in the Turkish population. Cephalalgia 2003;23:271–275.
6.
McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004;111:77–83.
7.
Merikangas KR, Angst J, Isler H. Migraine and psychopathology: results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990;47:849–853.
8.
Patel NV, Bigal ME, Kolodner KB, et al. Prevalence and impact of migraine and probable migraine in a health plan. Neurology 2004;63:1432–1438.
9.
Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment area follow-up study. Arch Gen Psychiatry 2000;57:945–950.
10.
Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life, and depression: a population-based case-control study. Neurology 2000;55:629–635.
11.
Oedegaard KJ, Neckelmann D, Mykletun A, et al. Migraine with and without aura: association with depression and anxiety disorder in a population-based study: The HUNT Study. Cephalalgia 2006;26:1–6.
12.
Zwart JA, Dyb G, Hagen K, et al. Depression and anxiety disorders associated with headache frequency: The Nord-Trondelag Health Study. Eur J Neurol 2003;10:147–152.
13.
Camarda C, Pipia C, Taglialavori A, et al. Comorbidity between depressive symptoms and migraine: preliminary data from the Zabut Aging Project. Neurol Sci 2008;suppl 1:S149–S151.
14.
Lantéri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain 2005;118:319–326.
15.
Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache 2006;46:1334–1343.
16.
Wang SJ, Juang KD, Fuh JL, Lu SR. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology 2007;68:1468–1473.
17.
Mercante JP, Peres MF, Guendler V, Zukerman E, Bernik MA. Depression in chronic migraine: severity and clinical features. Arq Neuropsiquiatr 2005;63:217–220.
18.
Radat F, Créac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005;25:519–522.
19.
Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB. The relative role of genetic and environmental factors in migraine without aura. Neurology 1999;53:995–999.
20.
Russell MB, Iselius L, Olesen J. Inheritance of migraine investigated by complex segregation analysis. Hum Genet 1995;96:726–730.
21.
Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. The inheritance of migraine with aura estimated by means of structural equation modelling. J Med Genet 1999;36:225–227.
22.
Mulder EJ, Van Baal C, Gaist D, et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 2003;6:422–431.
23.
Ziegler DK, Hur YM, Bouchard TJ, Jr., Hassanein RS, Barter R. Migraine in twins raised together and apart. Headache 1998;38:417–422.
24.
Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000;157:1552–1562.
25.
Pietrobon D. Migraine: new molecular mechanisms. Neuroscientist 2005;11:373–386.
26.
Muller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 2007;12:988–1000.
27.
Sleegers K, de Koning I, Aulchenko YS, et al. Cerebrovascular risk factors do not contribute to genetic variance of cognitive function: the ERF study. Neurobiol Aging 2007;28:735–741.
28.
Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999;53:537–542.
29.
Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385–401.
30.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scan 1983;67:361–370.
31.
Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977;106:203–214.
32.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002;52:69–77.
33.
Boichard D. PEDIG, a FORTRAN package for pedigree analysis studied for large populations. Paper presented at Proceeding of the 7th World Congress, Montpelier, France, August 19–23, 2002.
34.
Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198–1211.
35.
Henneman P, Aulchenko YS, Frants RR, van Dijk KW, Oostra BA, van Duijn CM. Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J Med Genet 2008;45:572–577.
36.
Pan L, Ober C, Abney M. Heritability estimation of sex-specific effects on human quantitative traits. Genetic Epidemiol 2007;31:338–347.
37.
Schur EA, Noonan C, Buchwald D, Goldberg J, Afari N. A twin study of depression and migraine: evidence for shared genetic vulnerability. Headache 2009;49:1493–1502.
Information & Authors
Information
Published In
Copyright
© 2010.
Publication History
Published online: January 13, 2010
Published in print: January 26, 2010
Notes
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Neurological Health in Sexual and Gender Minority Individuals, Seminars in Neurology, 44, 02, (193-204), (2024).https://doi.org/10.1055/s-0043-1778637
- Associations between Anxiety, Depression, Chronic Pain and Oral Health-Related Quality of Life, Happiness, and Polymorphisms in Adolescents’ Genes, International Journal of Environmental Research and Public Health, 20, 4, (3321), (2023).https://doi.org/10.3390/ijerph20043321
- Modern principles of primary headaches prevention in children and adolescents, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 123, 5, (31), (2023).https://doi.org/10.17116/jnevro202312305131
- Defining migraine days, based on longitudinal E-diary data, Cephalalgia, 43, 5, (033310242311666), (2023).https://doi.org/10.1177/03331024231166625
- Visual hypersensitivity in patients treated with anti‐calcitonin gene–related peptide (receptor) monoclonal antibodies, Headache: The Journal of Head and Face Pain, 63, 7, (926-933), (2023).https://doi.org/10.1111/head.14531
- Depression and anxiety in women with idiopathic intracranial hypertension compared to migraine: A matched controlled cohort study, Headache: The Journal of Head and Face Pain, 63, 2, (290-298), (2023).https://doi.org/10.1111/head.14465
- Depression and treatment with anti‐calcitonin gene related peptide ( CGRP) (ligand or receptor) antibodies for migraine , European Journal of Neurology, 31, 2, (2023).https://doi.org/10.1111/ene.16106
- Migraine and treatment-resistant depression, Treatment-Resistant Depression Part B, (149-173), (2023).https://doi.org/10.1016/bs.pbr.2023.05.001
- Genetics of migraine: Delineation of contemporary understanding of the genetic underpinning of migraine, Migraine Biology, Diagnosis, and Co-Morbidities, (85-103), (2023).https://doi.org/10.1016/B978-0-12-823356-6.00012-3
- Migraine, Migraine Disability, Trauma, and Discrimination in Sexual and Gender Minority Individuals, Neurology, 99, 14, (e1549-e1559), (2022)./doi/10.1212/WNL.0000000000200941
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.